Stapokibart injection for allergic rhinitis
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
Stapokibart is a new injection that works on a key pathway involved in allergy symptoms. This study will test if this once-every-two-week shot can help reduce runny nose, sneezing, and itchy eyes in people with allergic rhinitis (hay fever).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a doctor's diagnosis of allergic rhinitis (hay fever).
- You have a positive allergy test, either a skin test or a blood test for specific allergens.
- If you have asthma, it must be well-controlled and stable.
- You haven't taken certain biologic medications (like targeted allergy shots) in the last 10 weeks.
- You don't have any active sinus or lung infections right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to treat allergies by injecting allergy medicine directly into the tonsils. It may help people with hay fever who haven't gotten relief from standard treatments or want to avoid long-term medication.
This study tests if acupuncture on a nerve in the head (sphenopalatine ganglion) can help reduce symptoms of allergic rhinitis (hay fever) like sneezing and runny nose.
This trial tests whether PL-14, a new nasal spray, works better than saline spray at relieving seasonal allergy symptoms like sneezing, itching, and congestion. If it works well and is safe, it could offer patients a new way to manage allergies during pollen season.
This study tests a new injection called Stapokibart for people with seasonal allergic rhinitis (hay fever triggered by pollen or mold). The goal is to see if it helps control symptoms like sneezing, runny nose, and itchy eyes.
This study tests a new injectable medication called stapokibart to help teenagers with seasonal allergic rhinitis (hay fever). The goal is to see if this treatment reduces allergy symptoms like sneezing, congestion, and itchy eyes during allergy season.
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.